北方药学
北方藥學
북방약학
Journal of North Pharmacy
2015年
10期
14-15
,共2页
腹腔镜%药物治疗%卵巢打孔术%多囊卵巢综合征
腹腔鏡%藥物治療%卵巢打孔術%多囊卵巢綜閤徵
복강경%약물치료%란소타공술%다낭란소종합정
Laparoscopic%Medications%Ovarian drilling%Polycystic ovary syndrome
目的:探讨腹腔镜卵巢打孔术联合药物治疗多囊卵巢综合征性不孕的临床疗效. 方法:选取2013年6月~2015年3月我院收治的78例多囊卵巢综合征性不孕患者随机分为A组(n=39,采用药物保守治疗)和B组(n=39,采用腹腔镜卵巢打孔术联合药物治疗),比较两组治疗效果. 结果:B组并发症发生率、流产率均明显低于A组,差异有统计学意义(P<0.05);B组月经正常率、排卵率以及妊娠率均显著优于A组,差异有统计学意义(P<0.05). 结论:腹腔镜卵巢打孔术联合药物治疗多囊卵巢综合征性不孕的临床疗效显著,安全可靠,可提高妊娠率,降低并发症发生率和流产率,具有临床推广价值.
目的:探討腹腔鏡卵巢打孔術聯閤藥物治療多囊卵巢綜閤徵性不孕的臨床療效. 方法:選取2013年6月~2015年3月我院收治的78例多囊卵巢綜閤徵性不孕患者隨機分為A組(n=39,採用藥物保守治療)和B組(n=39,採用腹腔鏡卵巢打孔術聯閤藥物治療),比較兩組治療效果. 結果:B組併髮癥髮生率、流產率均明顯低于A組,差異有統計學意義(P<0.05);B組月經正常率、排卵率以及妊娠率均顯著優于A組,差異有統計學意義(P<0.05). 結論:腹腔鏡卵巢打孔術聯閤藥物治療多囊卵巢綜閤徵性不孕的臨床療效顯著,安全可靠,可提高妊娠率,降低併髮癥髮生率和流產率,具有臨床推廣價值.
목적:탐토복강경란소타공술연합약물치료다낭란소종합정성불잉적림상료효. 방법:선취2013년6월~2015년3월아원수치적78례다낭란소종합정성불잉환자수궤분위A조(n=39,채용약물보수치료)화B조(n=39,채용복강경란소타공술연합약물치료),비교량조치료효과. 결과:B조병발증발생솔、유산솔균명현저우A조,차이유통계학의의(P<0.05);B조월경정상솔、배란솔이급임신솔균현저우우A조,차이유통계학의의(P<0.05). 결론:복강경란소타공술연합약물치료다낭란소종합정성불잉적림상료효현저,안전가고,가제고임신솔,강저병발증발생솔화유산솔,구유림상추엄개치.
Objective: To analyze the laparoscopic ovarian drilling in combination with drug clinical efficacy infertility polycystic ovary syndrome. Methods:78 cases of infertile women with polycystic ovary syndrome in our hospital from 2013 June to 2015 March were randomly divided into group A (n = 39, treated with conservative medical)and group B (n = 39, treated with laparoscopic ovarian drilling in combination with drug therapy), compared between the two treatment groups. Results:Group B complication rate, miscarriage rate was significantly lower than the A group, there was statistical significance(P<0.05);group B rate of normal menstruation, ovulation and pregnancy rates were significantly better than the A group,there was statistical significance (P<0.05) Conclusion: Laparoscopic ovarian drilling in combination with drug clinical efficacy infertility polycystic ovary syndrome significantly, safe and reliable, can improve the pregnancy rate, reduce morbidity and abortion rates, with positive clinical use and promotion of value.